Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02042989
Title MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

lymphoma

Advanced Solid Tumor

Therapies

Ixazomib + Vorinostat

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST